查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1738429

数位疫苗市场－全球产业规模、份额、趋势、机会及预测，按设备类型、应用、地区及竞争情况细分，2020-2030 年

Digital Vaccine Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Device Type, By Application, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球数位疫苗市场价值为 12.8 亿美元，预计到 2030 年将达到 20.3 亿美元，复合年增长率为 7.98%。数位疫苗代表了预防性医疗保健的突破，利用基于软体的平台来调节神经认知和行为途径以调节免疫反应。与传统疫苗不同，这些数位解决方案使用智慧型手机、平板电脑和穿戴式装置来提供针对传染病、慢性病和精神健康状况的非侵入性、客製化干预措施。随着数位医疗技术的发展和对个人化、可扩展预防方法的需求增加，这个市场正在获得关注。不断增长的全球医疗保健需求，加上向综合、数据驱动的医疗服务的转变，支持了市场的扩张。数位疫苗定位于数位治疗和免疫接种的交叉点，正在透过创新、经济高效的预防保健解决方案重塑未来的公共卫生策略。

市场概览
预测期 2026-2030
2024年市场规模 12.8亿美元
2030年市场规模 20.3亿美元
2025-2030 年复合年增长率 7.98%
成长最快的领域 智慧型手机
最大的市场 北美洲

关键市场驱动因素

传染病和慢性病发生率上升

主要市场挑战

监管不确定性和复杂的审批流程

主要市场趋势

数位疫苗与更广泛的数位治疗生态系统的整合

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：数位疫苗市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依装置类型（智慧型手机、平板电脑、其他）
    • 依应用（糖尿病、传染病、心血管疾病、其他）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第六章：北美数位疫苗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章：欧洲数位疫苗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙

第八章：亚太数字疫苗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：南美数位疫苗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章：中东和非洲数位疫苗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 最新动态
  • 产品发布
  • 併购

第 13 章：全球数位疫苗市场：SWOT 分析

第 14 章：竞争格局

  • Pfizer Inc.
  • Moderna, Inc
  • AstraZeneca Plc
  • Johnson & Johnson Service Inc.
  • Sanofi
  • GSK Plc.
  • Novavax
  • BioNTech SE
  • Bharat Biotech Ltd
  • Klein Buendel, Inc

第 15 章：策略建议

简介目录
Product Code: 12817

The Global Digital Vaccine Market was valued at USD 1.28 Billion in 2024 and is projected to reach USD 2.03 Billion by 2030, growing at a CAGR of 7.98%. Digital vaccines represent a breakthrough in preventive healthcare, utilizing software-based platforms to engage neurocognitive and behavioral pathways for modulating immune responses. Unlike conventional vaccines, these digital solutions employ smartphones, tablets, and wearable devices to deliver non-invasive, customized interventions targeting infectious diseases, chronic illnesses, and mental health conditions. This market is gaining traction as digital health technologies evolve and the demand for personalized, scalable prevention methods rises. Increasing global healthcare needs, coupled with the shift towards integrated, data-driven care delivery, support the market's expansion. Positioned at the intersection of digital therapeutics and immunization, digital vaccines are reshaping future public health strategies through innovative, cost-effective preventive care solutions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.28 Billion
Market Size 2030USD 2.03 Billion
CAGR 2025-20307.98%
Fastest Growing SegmentSmartphones
Largest MarketNorth America

Key Market Drivers

Rising Incidence of Infectious and Chronic Diseases

The growing prevalence of infectious and chronic diseases is a primary catalyst propelling the Global Digital Vaccine Market. In 2021, non-communicable diseases accounted for over 43 million deaths, with 18 million classified as premature. These statistics are particularly concerning in low- and middle-income countries, where 82% of early deaths occurred. Concurrently, communicable diseases like tuberculosis, COVID-19, and influenza continue to impact global health, with TB alone causing 1.25 million deaths in 2023. The escalating burden on healthcare systems underscores the urgent need for preventive, scalable solutions. Digital vaccines offer timely, personalized interventions using software to manage and mitigate disease progression, thereby addressing a critical gap in traditional healthcare infrastructure.

Key Market Challenges

Regulatory Uncertainty and Complex Approval Processes

The absence of clear regulatory standards tailored for digital vaccines presents a considerable challenge for market growth. These software-based interventions straddle multiple domains-therapeutics, digital health, and preventive care-leading to ambiguity in classification and compliance. Regulatory bodies around the world differ in their evaluation and approval processes, which results in delays, inconsistent requirements, and elevated development costs. These factors deter investment, complicate commercialization, and hinder broader market adoption, especially in emerging regions.

Key Market Trends

Integration of Digital Vaccines with Broader Digital Therapeutics Ecosystems

A notable trend in the market is the merging of digital vaccines into comprehensive digital therapeutic ecosystems. Instead of operating as isolated tools, digital vaccines are increasingly becoming components of integrated health platforms that include AI diagnostics, remote monitoring, and personalized treatment. This ecosystem-based approach enhances clinical effectiveness through real-time analytics and interconnected care pathways. By fostering interoperability and cross-platform functionality, companies that prioritize ecosystem integration are poised to drive adoption and deliver greater value in preventive health.

Key Market Players

  • Pfizer Inc.
  • Moderna, Inc
  • AstraZeneca Plc
  • Johnson & Johnson Service Inc.
  • Sanofi
  • GSK Plc.
  • Novavax
  • BioNTech SE
  • Bharat Biotech Ltd
  • Klein Buendel, Inc

Report Scope:

In this report, the Global Digital Vaccine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Vaccine Market, By Device Type:

  • Smartphones
  • Tablets
  • Others

Digital Vaccine Market, By Application:

  • Diabetes
  • Infectious Diseases
  • Cardiovascular Diseases
  • Others

Digital Vaccine Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Vaccine Market.

Available Customizations:

Global Digital Vaccine market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Digital Vaccine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Device Type (Smartphones, Tablets, Others)
    • 5.2.2. By Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Digital Vaccine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Device Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Digital Vaccine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Device Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Digital Vaccine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Device Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Digital Vaccine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Device Type
        • 6.3.3.2.2. By Application

7. Europe Digital Vaccine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Device Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Digital Vaccine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Device Type
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Digital Vaccine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Device Type
        • 7.3.2.2.2. By Application
    • 7.3.3. Italy Digital Vaccine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Device Type
        • 7.3.3.2.2. By Application
    • 7.3.4. France Digital Vaccine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Device Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Digital Vaccine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Device Type
        • 7.3.5.2.2. By Application

8. Asia-Pacific Digital Vaccine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Device Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Digital Vaccine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Device Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Digital Vaccine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Device Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Digital Vaccine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Device Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Digital Vaccine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Device Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Digital Vaccine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Device Type
        • 8.3.5.2.2. By Application

9. South America Digital Vaccine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Device Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Digital Vaccine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Device Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Digital Vaccine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Device Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Digital Vaccine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Device Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Digital Vaccine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Device Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Digital Vaccine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Device Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Digital Vaccine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Device Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Digital Vaccine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Device Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Digital Vaccine Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Pfizer Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. Moderna, Inc
  • 14.3. AstraZeneca Plc
  • 14.4. Johnson & Johnson Service Inc.
  • 14.5. Sanofi
  • 14.6. GSK Plc.
  • 14.7. Novavax
  • 14.8. BioNTech SE
  • 14.9. Bharat Biotech Ltd
  • 14.10.Klein Buendel, Inc

15. Strategic Recommendations